The existing drug holds promise as a treatment for the rare genetic disorder
Media advisory Thursday, May 30, 2024 NIH researchers find new pathways to treatment for autoimmune polyendocrine syndrome type 1. What A drug approved to treat several autoimmune diseases and cancers successfully alleviated the symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1). The researchers identified the treatment based on their discovery…